Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained

How do the eligibility criteria for the monarchE and NATALEE clinical trials compare? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002403?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Mar 31, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained

0:00 27:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 27 minutes long.

When was this Keeping Current CME episode published?

This episode was published on March 31, 2025.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!